Literature DB >> 22696669

Periodontal infection in adult-onset Still's disease patient: clinical and haematological considerations.

Larissa Pessoa1, Virgilio Galvão, Clarissa Ferreira, Leopoldo Santos Neto.   

Abstract

In this case report, the authors described the first case of a patient with adult-onset Still's disease (AOSD) who presents advanced periodontal infection. AOSD is a rare systemic inflammatory disorder of unknown aetiology, characterised by spiking fever, usually exceeding 39°C, an evanescent salmon pink rash, arthritis and multiorgan involvement. Periodontal infection is a pathogen-induced oral inflammatory disease affecting the supporting tissues of teeth and is currently considered as a risk factor for cardiovascular disease. Several cytokines capable of inducing systemic effects are produced during the course of this infection and the values of serum markers of inflammation, such as C reactive protein (CRP), may significantly decrease after periodontal treatment. Although AOSD can produce elevations in CRP, similar increase may be produced by periodontal infection, suggesting the need for medical and dental diagnosis when evaluating the sources of acute-phase responses in systemic autoimmune disease patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22696669      PMCID: PMC3083007          DOI: 10.1136/bcr.02.2011.3803

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management.

Authors:  J Wajed; Y Ahmad; P N Durrington; I N Bruce
Journal:  Rheumatology (Oxford)       Date:  2003-07-16       Impact factor: 7.580

Review 2.  Diagnosis and management of adult onset Still's disease.

Authors:  P Efthimiou; P K Paik; L Bielory
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

3.  Preliminary criteria for classification of adult Still's disease.

Authors:  M Yamaguchi; A Ohta; T Tsunematsu; R Kasukawa; Y Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; T Ota
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

4.  Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.

Authors:  B Fautrel; G Le Moël; B Saint-Marcoux; P Taupin; S Vignes; S Rozenberg; A C Koeger; O Meyer; L Guillevin; J C Piette; P Bourgeois
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

Review 5.  Adult Still's disease: review of 228 cases from the literature.

Authors:  A Ohta; M Yamaguchi; H Kaneoka; T Nagayoshi; M Hiida
Journal:  J Rheumatol       Date:  1987-12       Impact factor: 4.666

Review 6.  Updating on the pathogenesis of systemic lupus erythematosus.

Authors:  R Gualtierotti; M Biggioggero; A E Penatti; P L Meroni
Journal:  Autoimmun Rev       Date:  2010-09-21       Impact factor: 9.754

7.  Exacerbation of adult-onset Still's disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration.

Authors:  Kaichi Kaneko; Makoto Kaburaki; Sei Muraoka; Nahoko Tanaka; Tatsuhiro Yamamoto; Yoshie Kusunoki; Haruo Abe; Hirahito Endo; Shinichi Kawai
Journal:  Int J Rheum Dis       Date:  2010-10       Impact factor: 2.454

8.  Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience.

Authors:  Fan Lian; Yu Wang; Xiuyan Yang; Hanshi Xu; Liuqin Liang
Journal:  Rheumatol Int       Date:  2010-08-27       Impact factor: 2.631

Review 9.  "Gum bug, leave my heart alone!"--epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis.

Authors:  M Kebschull; R T Demmer; P N Papapanou
Journal:  J Dent Res       Date:  2010-07-16       Impact factor: 6.116

10.  Still's disease in children and adults: a distinct pattern of acute-phase proteins.

Authors:  M Sobieska; K Fassbender; A Aeschlimann; P Bourgeois; S Mackiewicz; W Müller
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.